ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
35 announcements with these filters
Entero delivered strong FY26 performance meeting all guidance parameters. Revenue grew 29.3% to ₹6,591 Cr with EBITDA margins expanding to 4.0%, driven by organic growth and 7 strategic acquisitions.
Entero Healthcare Solutions Ltd reported revenue from operations of ₹1,910 Cr (+42.6% YoY) and net profit of ₹45.1 Cr (+43.6% YoY) for Q4 FY26.
Entero Healthcare Solutions approved its FY26 audited financial results and several strategic re-appointments. The board also cleared the acquisition of Vishal Surgicals to expand operations.
Entero Healthcare Solutions scheduled a board meeting for May 25, 2026, to approve fiscal 2026 financial results. Trading window remains closed until 48 hours post-declaration.
Entero Healthcare Solutions Limited announced that the Regional Director has sanctioned the Scheme of Amalgamation of its wholly-owned subsidiaries, Chethana Pharma Distributors and CPD Pharma, with Rada Medisolutions. The consolidation aims to improve operational efficiencies and simplify the group structure. The scheme became effective from April 15, 2025.